Australia based Syrah Resources has secured a waiver for default events under its United States International Development Finance Corporation (DFC) loan of $150m.
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...
Some results have been hidden because they may be inaccessible to you